Catalyst Wire Dossier Catalyst Wire Dossier

Isosorbide Dinitrate and Hydralazine Hydrochloride

Isosorbide Dinitrate and Hydralazine Hydrochloride · Ingenus Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Isosorbide Dinitrate and Hydralazine Hydrochloride, covering 2022-04-06 to 2024-01-30. Get the full timeline:

Most recent: FDA Approved: ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE — Supplemental Application (A2A Integrated Pharmaceuticals)

See pricing